Author

G. Vavouras Syrigos

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

A. Dirlam· 1 shared I. Gruska· 1 shared K. Hamprecht· 1 shared L. Wiebusch· 1 shared M. Feige· 1 shared M. Schindler· 1 shared R. Businger· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

7 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

A. Dirlam

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

MicrobiologybioRxivFeb 1, 2023

Abemaciclib restricts HCMV replication by suppressing pUL97-mediated phosphorylation of SAMHD1

G. Vavouras Syrigos, M. Feige, A. Dirlam…·M. Schindler

This study shows that Abemaciclib inhibits HCMV replication by blocking pUL97-mediated SAMHD1 phosphorylation, establishing SAMHD1 as a therapeutic target.

DOI 10.1016/j.antiviral.2023.105689

humanproteomics

𝕏 PostBluesky